Skip to main content

Pharmaco Vigilance

Italiano   English

Search form

  • Home
  • Perspectives
  • Case Reports
  • Focus on
  • Columns
  • News
  • Links
  • About us
  • Contacts

Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial

© 2011-2020 | Zadig srl | P.IVA: 10983300152